These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9494595

  • 1. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
    Strang P, Nilsson S, Brändstedt S, Sehlin J, Borghede G, Varenhorst E, Bandman U, Borck L, Englund G, Selin L.
    Anticancer Res; 1997; 17(6D):4717-21. PubMed ID: 9494595
    [Abstract] [Full Text] [Related]

  • 2. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
    Heidenreich A, Hofmann R, Engelmann UH.
    J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
    [Abstract] [Full Text] [Related]

  • 3. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 4. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P, Hering F, Campagnari JC.
    Prostate Cancer Prostatic Dis; 2004 Jul; 7(4):350-4. PubMed ID: 15534620
    [Abstract] [Full Text] [Related]

  • 5. A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy.
    Piga A, Bracci R, Ferretti B, Sandri P, Nortilli R, Acito L, Pancotti A, Di Furia L, Carle F, Cellerino R.
    J Exp Clin Cancer Res; 1998 Jun; 17(2):213-7. PubMed ID: 9700583
    [Abstract] [Full Text] [Related]

  • 6. [The effects of clodronate for the pain treatment of bone metastasis due to prostate cancer].
    Ozyuvaci E, Altan A, Demir C.
    Agri; 2005 Jan; 17(1):49-53. PubMed ID: 15791501
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer and bone metastases. The effect of clodronate.
    Kylmälä T.
    Ann Chir Gynaecol; 1998 Jan; 87(1):59-60. PubMed ID: 9598233
    [No Abstract] [Full Text] [Related]

  • 8. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.
    Ernst DS, Tannock IF, Winquist EW, Venner PM, Reyno L, Moore MJ, Chi K, Ding K, Elliott C, Parulekar W.
    J Clin Oncol; 2003 Sep 01; 21(17):3335-42. PubMed ID: 12947070
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
    Heidenreich A.
    Urologe A; 1997 Nov 01; 36(6):568. PubMed ID: 9487597
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
    Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P, Quadramet 424Sm10/11 Study Group.
    Urology; 2004 May 01; 63(5):940-5. PubMed ID: 15134985
    [Abstract] [Full Text] [Related]

  • 12. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K, Jereczek-Fossa B, Badzio A, Jassem J.
    Neoplasma; 1999 May 01; 46(5):317-22. PubMed ID: 10665850
    [Abstract] [Full Text] [Related]

  • 13. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
    Kylmälä T, Tammela TL, Lindholm TS, Seppänen J.
    Ann Chir Gynaecol; 1994 May 01; 83(4):316-9. PubMed ID: 7537482
    [Abstract] [Full Text] [Related]

  • 14. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
    Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO.
    J Clin Oncol; 2003 Dec 01; 21(23):4277-84. PubMed ID: 14581438
    [Abstract] [Full Text] [Related]

  • 15. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE, McCloskey EV, Dewar JA, Body JJ, Cameron DA, Harnett AN, Ruutu M, Purohit OP, Tähtelä R, Coleman RE.
    Calcif Tissue Int; 2007 Nov 01; 81(5):341-51. PubMed ID: 17874331
    [Abstract] [Full Text] [Related]

  • 16. One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
    Rovetta G, Maggiani G, Molfetta L, Monteforte P.
    Drugs Exp Clin Res; 2001 Nov 01; 27(2):77-81. PubMed ID: 11392057
    [Abstract] [Full Text] [Related]

  • 17. The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.
    Han SH, de Klerk JM, Tan S, van het Schip AD, Derksen BH, van Dijk A, Kruitwagen CL, Blijham GH, van Rijk PP, Zonnenberg BA.
    J Nucl Med; 2002 Sep 01; 43(9):1150-6. PubMed ID: 12215552
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
    James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T, Phung D, Dawson NA.
    Eur Urol; 2009 May 01; 55(5):1112-23. PubMed ID: 19042080
    [Abstract] [Full Text] [Related]

  • 19. Transient relief of metastatic cancer bone pain by oral administration of etidronate.
    Iwamoto J, Takeda T, Ichimura S.
    J Bone Miner Metab; 2002 May 01; 20(4):228-34. PubMed ID: 12115069
    [Abstract] [Full Text] [Related]

  • 20. [Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma].
    Vorreuther R, Klotz T, Engelking R.
    Urologe A; 1992 Mar 01; 31(2):63-6. PubMed ID: 1373255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.